| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 05/26/2004 | CN1498646A Ointment for benefiting lung made from crocodile |
| 05/26/2004 | CN1498618A Injection of hydrochloric 'Azasiqiong' powder and its prepn. method |
| 05/26/2004 | CN1498617A Preparation containing Cetirizine Hydrochloride and hydrochloric pseudoephedrine and its prepn. method |
| 05/26/2004 | CN1498615A Preparation made from effective position of red sage root, and its prepn. method |
| 05/26/2004 | CN1498614A Camphor spraying agent as well as its producing method and product |
| 05/26/2004 | CN1498613A Combination of 5-HT3 receptor antagonist of spraying administration for treating nasal mucosa |
| 05/26/2004 | CN1498612A Medicament form of tatin class |
| 05/26/2004 | CN1498536A Composite antibiosis material of natural organic matrix and inorganic nano silver as well as industrialized preparing technique |
| 05/26/2004 | CN1150938C Capsule for treating gynaecologic inflammation, and its prepn. process |
| 05/26/2004 | CN1150932C Intravenous injection of curing cardiovascular system diseases and its preparing method |
| 05/26/2004 | CN1150929C Malian granule for clearing away liver fever |
| 05/26/2004 | CN1150920C Medicine for treating female dimacteric syndrome and its preparing process |
| 05/26/2004 | CN1150919C Paste for eradicating liver disease and preparing method |
| 05/26/2004 | CN1150915C Prescription of'strong heart first-aid dropping pill'and its preparing process |
| 05/26/2004 | CN1150904C Pharmaceutical compositions for oral administration of molecular iodine |
| 05/26/2004 | CN1150902C Prescription of preparing moxapride citrate |
| 05/26/2004 | CN1150900C Pharmaceutical compositions for oral administration, comprising active substance and cyclodextrin |
| 05/26/2004 | CN1150898C Utilization of alkyl hydrogen fumerates for treating psoriasis, psoriatic arthrits, neurodermatitis and regional enterits |
| 05/26/2004 | CN1150897C Injectable composition of non-steroidal anti-inflammatory drugs |
| 05/26/2004 | CN1150895C Dry Powder for inhalation |
| 05/26/2004 | CN1150894C Prepn. process of oral coated medicine grains |
| 05/26/2004 | CN1150893C Pharmaceutical compsn. having two coating layers |
| 05/26/2004 | CN1150892C Fish gelatinous composition for use as ingredient in tablets |
| 05/26/2004 | CN1150891C Method for producing solent-free non-crystalline biologically active substances |
| 05/26/2004 | CN1150890C Medicinal aerosol formulations |
| 05/26/2004 | CN1150889C Oral Micro-emulsion composition of silybin |
| 05/26/2004 | CN1150888C Peroral active agent suspension |
| 05/25/2004 | US6740664 A new class of quinolone antibiotic (e.g., moxifloxacin) is useful for treating otic, opthalmic or nasal infections attributed to a microbacterium species selected from microbacterium otitidis or microbacterium alconae |
| 05/25/2004 | US6740660 For amelioration of erectile dysfunction in a mammal without causing substantial intolerable adverse side effects to mammal |
| 05/25/2004 | US6740653 An oil in water emulsion comprising an alkaline to increase the solubility of aza compound; control infestations, infections of livestock or domestic animals; topical application, veterinary medicine |
| 05/25/2004 | US6740652 Topical administration of an ophthalmologically effective amount of an oxazolidinone derivative |
| 05/25/2004 | US6740639 L-tyrosyl-d-alanyl-glycyl-n-methylphenylalanyl-glycyl -isopropylamide and cyclodextrin derivatives; analgesic, antiinflammatory, nonaddictive properties |
| 05/25/2004 | US6740634 Biologically active peptide (an lh-rh derivative), hydroxynaphthoic acid (3-hydroxy-2-naphthoic acid) and a biodegradable polymer (lactic acid-glycolic acid copolymer); prostatic cancer or hypertrophy, endometriosis, hysteromyoma |
| 05/25/2004 | US6740502 Chelation in presence of protease; bioavailability |
| 05/25/2004 | US6740341 Spacing layer in combination with a taste masking layer which rapidly releases in the stomach at lower ph, but does not dissolve in the mouth at a neutral to basic ph |
| 05/25/2004 | US6740340 Pharmaceutical tablets comprising an NSAID and a prostaglandin |
| 05/25/2004 | US6740339 Preparation comprising active ingredient, saccharide or sugar alcohol with mean particle diameter of 5 mu m up to 90 mu m, saccharide or sugar alcohol with mean particle diameter of 90 mu m to 500 mu m, disintegrating agent, and cellulose compound |
| 05/25/2004 | US6740338 Reduced form of Cenzyme Q in high bioavailability stable oral dosage form |
| 05/25/2004 | US6740337 Stability |
| 05/25/2004 | US6740335 Liposomal camptothecin formulations |
| 05/25/2004 | US6740333 Suppository and composition comprising at least one polyethylene glycol |
| 05/25/2004 | US6740332 Edible film formulations containing maltodextrin |
| 05/25/2004 | US6740331 Apparatus for drug delivery within vessel including radially expandable longitudinal solid struts defining cage expandable from delivery configuration to deployed configuration for engaging interior surface of vessel, drug within cage |
| 05/25/2004 | US6740320 Recombinant P53 adenovirus methods and compositions |
| 05/25/2004 | US6740310 Porous particles comprising excipients for deep lung delivery |
| 05/25/2004 | US6740309 Delivery of compounds for the treatment of migraine through an inhalation route |
| 05/25/2004 | US6740308 Composition comprising condensation aerosol formed by volatilizing antihistamine under conditions effective to produce heated vapor and condensing to form condensation aerosol particles having less than 5% degradation products |
| 05/25/2004 | US6740307 Delivery of β-blockers through an inhalation route |
| 05/25/2004 | US6740306 Imidazotriazinone-containing compositions for nasal administration |
| 05/25/2004 | US6740162 Method for treating particulate material with a coating medium and an apparatus for carrying out the method |
| 05/25/2004 | US6740077 Implant with permeable element |
| 05/25/2004 | US6740076 Ultrasonic septum monitoring for implantable medical devices |
| 05/25/2004 | US6740075 Ambulatory medical apparatus with hand held communication device |
| 05/25/2004 | US6740060 Gasket for bypass type prefilled syringe |
| 05/25/2004 | US6740059 Devices, systems and methods for patient infusion |
| 05/25/2004 | CA2267497C Edible, low calorie compositions of a carrier and an active ingredient and methods for preparation thereof |
| 05/25/2004 | CA2185457C Use of nitric oxide-releasing polymers to treat restenosis and related disorders |
| 05/25/2004 | CA2159624C Method of encapsulating substances in biocapsules |
| 05/25/2004 | CA2153893C The preparation of colloidal aqueous solutions of active substances of low solubility and a lipid therefor |
| 05/25/2004 | CA2140468C Percutaneous administration tape preparation |
| 05/25/2004 | CA2101871C Transdermic pharmaceutical preparation |
| 05/25/2004 | CA2046337C Improved transdermal system for the administration of pharmacological compounds under ph-controlled conditions |
| 05/22/2004 | CA2417634A1 Plastic and elastic protein copolymers |
| 05/21/2004 | WO2004042068A2 Injectable and bioadhesive polymeric hydrogels as well as related methods of enzymatic preparation |
| 05/21/2004 | WO2004041324A2 Transdermal delivery of fentanyl |
| 05/21/2004 | WO2004041317A1 Self-folding polymer microparticles |
| 05/21/2004 | WO2004041303A1 Oral formulation or botulinum toxin and use thereof for treating peptic ulcers and gastroesophageal reflux disease |
| 05/21/2004 | WO2004041298A1 Liposomal composition comprising haptotactic peptides |
| 05/21/2004 | WO2004041287A1 Delivery composition and method |
| 05/21/2004 | WO2004041270A1 Percutaneous absorption preparations containing 3-methyl-1-phenyl-2-pyrazolin-5-one |
| 05/21/2004 | WO2004041261A1 A kind of camphor spray and its preparation and a product containing it |
| 05/21/2004 | WO2004041255A1 Dosage form providing ascending release of liquid formulation |
| 05/21/2004 | WO2004041254A1 Coating of a particulate material with an organic solvent-based coating composition |
| 05/21/2004 | WO2004041253A1 Wet granulation process |
| 05/21/2004 | WO2004041252A1 Controlled release carvedilol compositions |
| 05/21/2004 | WO2004041251A1 Microcapsules having multiple shells and method for the preparation thereof |
| 05/21/2004 | WO2004041250A2 Nanoparticulate fibrate formulations |
| 05/21/2004 | WO2004041249A1 Microemulsion concentrate for oral administration of water-insoluble anti-cold drug and method for preparing same |
| 05/21/2004 | WO2004041247A2 Geodate delivery vehicles |
| 05/21/2004 | WO2004041246A1 Pharmaceutical formulation providing an increased biovailability of hydrophobic drugs |
| 05/21/2004 | WO2004041245A2 Pharmaceutical solutions comprising a modafinil compound and their use for the manufacture of a medicament for treating different diseases |
| 05/21/2004 | WO2004041244A2 Oral extended release tablets and methods of making and using the same |
| 05/21/2004 | WO2004041242A1 Implantable medical device for controlled release of a substance |
| 05/21/2004 | WO2004041241A2 Implantable structure for prolonged and controlled release of an active principle |
| 05/21/2004 | WO2004041240A1 Controlled and continued delivery of rifaximin and/or other substances |
| 05/21/2004 | WO2004041239A1 Transmucosal pharmaceutical administration form |
| 05/21/2004 | WO2004041230A1 Base for oral composition and oral composition |
| 05/21/2004 | WO2004041229A1 Base for oral composition and oral composition |
| 05/21/2004 | WO2004041206A2 Waxy matrix dosage forms |
| 05/21/2004 | WO2004041195A2 Pharmaceutical formulations targeting specific regions of the gastrointestinal tract |
| 05/21/2004 | WO2004041188A2 Compositions and methods for transdermal oxybutynin therapy |
| 05/21/2004 | WO2004041187A2 Compositions and methods for transdermal oxybutynin therapy |
| 05/21/2004 | WO2004041166A2 Dosage forms containing stabilized choline and method for preparing same |
| 05/21/2004 | WO2004041158A2 Rifalazil compositions and therapeutic regimens |
| 05/21/2004 | WO2004041153A2 Pharmaceutical composition including low dosages of desmopressin |
| 05/21/2004 | WO2004041137A1 Disposable pharmaceutical or cosmetic product applicator |
| 05/21/2004 | WO2004041118A2 Therapeutic compositions for drug delivery to and through covering epithelia |
| 05/21/2004 | WO2004041103A2 Oral hygiene system and method of treatment |
| 05/21/2004 | WO2004041068A2 Guided capsule for wireless endoscopy, biopsy, and drug delivery |
| 05/21/2004 | WO2004040992A1 Medicated comestibles |